Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study

BACKGROUND: In clinical practice, the same chemotherapeutic agents are occasionally reused (re-challenge) after failure of all available standard chemotherapy options for metastatic colorectal cancer (mCRC). However, the benefits of re-challenge chemotherapy (Re-Cx) are unclear. This retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Masashi, Takashima, Atsuo, Nagata, Yusuke, Sawada, Ryoichi, Aoki, Masahiko, Imazeki, Hiroshi, Hirano, Hidekazu, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Kato, Ken, Saruta, Masayuki, Boku, Narikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462714/
https://www.ncbi.nlm.nih.gov/pubmed/34559818
http://dx.doi.org/10.1371/journal.pone.0257551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462714/
https://www.ncbi.nlm.nih.gov/pubmed/34559818
http://dx.doi.org/10.1371/journal.pone.0257551

Ejemplares similares